Why Pfizer’s Shares Are Slipping 7.6% Today

What happened
Shares are tumbling after Pfizer(NYSE:PFE) reported that its breast cancer drug, Ibrance, came up shy in a phase 3 trial evaluating its use alongside adjuvant endocrine therapy in earl…
Read More